Lunch with FTI: Medication Safety
Ensuring Your Health System Has Implemented an Impactful Medication Safety Program
June 20, 2019
Lunch with FTI: Medication SafetyDownloads
Date: Wednesday, June 19, 2019
Length: 30 minutes
Medication safety has long been one of the Joint Commission’s key priorities. Its importance has recently been brought into public focus by the news of criminal charges against a registered nurse in Tennessee who was involved in a fatal medication error.
These errors can pose grave risks not only for patients and caregivers, but also for a Hospital’s reputation and Medicare reimbursement status.
FTI Consulting, in this joint presentation with Aspirus Health System, challenges hospital executives and pharmacy leaders to take a closer look at their safety culture and systems in place to increase error reporting and reduce the likelihood of medication errors reaching patients.
We will discuss American Society of Health System Pharmacy and Institute for Safe Medication Practices recommendations — such as consistent use of barcoding and leveraging of multidisciplinary medication safety committees — to help reduce risks to patients, employees and your organization.
- Foundational Medication Safety Program Tasks
- Medication Safety Committee
- Typical Downfalls in Practice
Who Should Attend?
- Hospital C-Suite interested in reducing medication error risk
- Directors and VPs of Pharmacy
- Chief Medical Officers
- VPs of Quality/Risk Management
FTI Consulting Health Solutions
Jigar Thakkar is a Managing Director at FTI Consulting. He is part of the Health Solutions segment within the Healthcare Operations practice, where he specializes in Pharmacy. Jigar’s experience in Pharmacy includes strategic planning, design, operations, compliance, and improvement of an organization’s medication management system. He has experience in implementing best practice pharmacy models and has expertise in pharmacy supply chain management, pharmacy productivity, and pharmacy related regulatory and accreditation compliance such as the 340B Drug Pricing Program. Jigar has a broad range of pharmacy experience in addition to the hospital segment that includes Retail, Specialty, Infusion, Hematology/Oncology, Long Term Care, Capital Equity directed projects of due diligence of mergers and acquisitions of large retail and specialty pharmacy chains. Jigar has also completed several projects of large health system mergers as they relate to pharmacy integration and implementation of resulting synergies.
Jessica Bessner, PharmD, BCGP
Director of Pharmacy
Aspirus Keweenaw Hospital
Jessica Bessner is a Pharmacy Director at Aspirus Keweenaw Hospital and the current President of the Michigan Pharmacists Association. Her responsibilities include two hospital pharmacies and two retail pharmacies as well as Long Term Care medication provision and consulting. Jessica's experience in Pharmacy includes leadership, project management, operations, medication safety, 340b analytics, and automation in both the nonprofit and for-profit sectors.